1. Home
  2. GDTC vs SIDU Comparison

GDTC vs SIDU Comparison

Compare GDTC & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • SIDU
  • Stock Information
  • Founded
  • GDTC 2018
  • SIDU 2012
  • Country
  • GDTC Singapore
  • SIDU United States
  • Employees
  • GDTC N/A
  • SIDU N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • SIDU Telecommunications Equipment
  • Sector
  • GDTC Health Care
  • SIDU Telecommunications
  • Exchange
  • GDTC Nasdaq
  • SIDU Nasdaq
  • Market Cap
  • GDTC 28.0M
  • SIDU 30.0M
  • IPO Year
  • GDTC 2023
  • SIDU 2021
  • Fundamental
  • Price
  • GDTC $2.02
  • SIDU $2.01
  • Analyst Decision
  • GDTC Buy
  • SIDU
  • Analyst Count
  • GDTC 1
  • SIDU 0
  • Target Price
  • GDTC $5.00
  • SIDU N/A
  • AVG Volume (30 Days)
  • GDTC 7.2K
  • SIDU 667.8K
  • Earning Date
  • GDTC 01-01-0001
  • SIDU 08-18-2025
  • Dividend Yield
  • GDTC N/A
  • SIDU N/A
  • EPS Growth
  • GDTC N/A
  • SIDU N/A
  • EPS
  • GDTC N/A
  • SIDU N/A
  • Revenue
  • GDTC $368,838.00
  • SIDU $3,860,985.00
  • Revenue This Year
  • GDTC $5.37
  • SIDU $144.49
  • Revenue Next Year
  • GDTC N/A
  • SIDU N/A
  • P/E Ratio
  • GDTC N/A
  • SIDU N/A
  • Revenue Growth
  • GDTC N/A
  • SIDU N/A
  • 52 Week Low
  • GDTC $1.20
  • SIDU $1.14
  • 52 Week High
  • GDTC $4.05
  • SIDU $7.65
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 40.10
  • SIDU 66.78
  • Support Level
  • GDTC $2.01
  • SIDU $1.71
  • Resistance Level
  • GDTC $2.22
  • SIDU $2.05
  • Average True Range (ATR)
  • GDTC 0.09
  • SIDU 0.11
  • MACD
  • GDTC -0.02
  • SIDU 0.03
  • Stochastic Oscillator
  • GDTC 5.88
  • SIDU 97.44

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Share on Social Networks: